Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara C Mitchell

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|June 22, 2019
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind studyGeorgina V Long, Reinhard Dummer, Omid Hamid, et al.
Cell Reports|May 12, 2021
Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cellsLaura M McLane, Shin Foong Ngiow, Zeyu Chen, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2021
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006Omid Hamid, Caroline Robert, Adil Daud, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Journal for Immunotherapy of Cancer|December 23, 2021
Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC functionHuaishan Wang, Hui Chen, Shujing Liu, et al.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
Immunity|May 13, 2020
Developmental Relationships of Four Exhausted CD8<sup>+</sup> T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control MechanismsJean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
JAMA Dermatology|September 18, 2024
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic VariantsJames J Abbott, Angela J Jiang, Rama Godse, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|June 22, 2019
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind studyGeorgina V Long, Reinhard Dummer, Omid Hamid, et al.
Cell Reports|May 12, 2021
Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cellsLaura M McLane, Shin Foong Ngiow, Zeyu Chen, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2021
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006Omid Hamid, Caroline Robert, Adil Daud, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Journal for Immunotherapy of Cancer|December 23, 2021
Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC functionHuaishan Wang, Hui Chen, Shujing Liu, et al.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
Immunity|May 13, 2020
Developmental Relationships of Four Exhausted CD8<sup>+</sup> T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control MechanismsJean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
JAMA Dermatology|September 18, 2024
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic VariantsJames J Abbott, Angela J Jiang, Rama Godse, et al.
Pageof 7